 |
|
Patterns of Use, Expenditures, and Perceived Efficacy of Complementary and Alternative Therapies in HIV-Infected Patients
Kathleen M. Fairfield, MD;
David M. Eisenberg, MD;
Roger B. Davis, ScD;
Howard Libman, MD;
Russell S. Phillips, MD
Arch Intern Med. 1998;158:2257-2264.
Background Complementary and alternative medicine (CAM) use is common in the general population, accounting for substantial expenditures. Among patients with human immunodeficiency virus (HIV) infection, few data are available on the prevalence, costs, and patterns of alternative therapy use.
Methods We carried out detailed telephone surveys and medical chart reviews for 289 active patients with HIV in a general medicine practice at a university-based teaching hospital in Boston, Mass. Data were collected on prevalence and patterns of CAM use, out-of-pocket expenditures, associated outcomes, and correlates of CAM use.
Results Of 180 patients who agreed to be interviewed, 122 (67.8%) used herbs, vitamins, or dietary supplements, 81 (45.0%) visited a CAM provider, and 43 (23.9%) reported using marijuana for medicinal purposes in the previous year. Patients who saw CAM providers made a median of 12 visits per year to these providers compared with 7 visits per year to their primary care physician and nurse practitioner. Mean yearly out-of-pocket expenditures for CAM users totaled $938 for all therapies. For the main reason CAM was used, respondents found therapies "extremely" or "quite a bit" helpful in 81 (81.0%) of 100 reports of supplement use, in 76 (65.5%) of 116 reports of CAM provider use, and in 27 (87%) of 31 reports of marijuana use. In multivariable models, college education (odds ratio [OR]=3.7, 95% confidence interval [CI]=1.9-7.1) and fatigue (OR=2.7, 95% CI=1.4-5.2) were associated with CAM provider use; memory loss (OR=2.3, 95% CI=1.1-4.8) and fatigue (OR=0.4, 95% CI=0.2-0.9) were associated with supplement use; and weight loss (OR=2.6, 95% CI=1.2-5.6) was associated with marijuana use.
Conclusions Patinets with HIV infection use CAM, including marijuana, at a high rate; make frequent visits to CAM providers; incur substantial expenditures; and report considerable improvement with these treatments. Clinical trials of frequently used CAMs are needed to inform physicians and patients about therapies that may have measurable benefit or measurable risk.
From the Division of General Medicine and Primary Care (Drs Fairfield, Eisenberg, Davis, Libman, and Phillips) and the Center for Alternative Medicine Research (Dr Eisenberg), Department of Medicine, Beth Israel Deaconess Medical Center, and Harvard Medical School, Boston, Mass.
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
RELATED LETTER
Carnitine Stands on Its Own in HIV Infection Treatment
Guiseppe Famularo, Claudio De Simone, and Grazia Cifone
Arch Intern Med. 1999;159(10):1143-1144.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Non-conventional practices and immune functioning among individuals receiving conventional care for HIV
Nightingale et al.
J Health Psychol 2011;16:1241-1250.
ABSTRACT
Medical Marijuana in HIV-Positive Patients: What Do We Know?
Cinti
Journal of the International Association of Physicians in AIDS Care (JIAPAC 2009;8:342-346.
ABSTRACT
Marijuana Effectiveness as an HIV Self-Care Strategy
Corless et al.
Clin Nurs Res 2009;18:172-193.
ABSTRACT
The Effect of Micronutrient Supplementation on Disease Progression and Death in Simian Immunodeficiency Virus-Infected Juvenile Male Rhesus Macaques
Goldin et al.
The Journal of Infectious Disease 2005;192:311-318.
ABSTRACT
| FULL TEXT
The Persistence and Resurgence of Medical Pluralism
Goldstein
Journal of Health Politics, Policy and Law 2004;29:925-946.
Sociocultural Barriers to the Use of Complementary and Alternative Medicine for HIV
Foote-Ardah
Qual Health Res 2004;14:593-611.
ABSTRACT
Fatigue in cancer patients receiving chemotherapy: an analysis of published studies
Iop et al.
Ann Oncol 2004;15:712-720.
ABSTRACT
| FULL TEXT
Influence of Goldenseal Root on the Pharmacokinetics of Indinavir
Sandhu et al.
J Clin Pharmacol 2003;43:1283-1288.
ABSTRACT
| FULL TEXT
A Behavioral-Medicine Program in HIV: Implications for Quality of Life
Nicholas et al.
J Holist Nurs 2003;21:163-178.
ABSTRACT
Complementary Therapy Use in Persons with HIV/AIDS
Kirksey et al.
J Holist Nurs 2002;20:264-278.
ABSTRACT
Acupuncture for Asthma: Fact or Fiction?
Varon et al.
Chest 2002;121:1387-1388.
FULL TEXT
Complementary and Alternative Medicine (CAM) Use by Older Adults: A Comparison of Self-Report and Physician Chart Documentation
Cohen et al.
J Gerontol A Biol Sci Med Sci 2002;57:M223-M227.
ABSTRACT
| FULL TEXT
The Effect of Garlic Supplements on the Pharmacokinetics of Saquinavir
Piscitelli et al.
Clinical Infectious Diseases 2002;34:234-238.
ABSTRACT
| FULL TEXT
Significant Drug Interactions in the HIV Patient
Conry
Journal of Pharmacy Practice 2000;13:499-514.
ABSTRACT
Self-reported medical use of marijuana: a survey of the general population
Ogborne et al.
CMAJ 2000;162:1685-1686.
FULL TEXT
Use of Complementary Therapies for Arthritis among Patients of Rheumatologists
Rao et al.
ANN INTERN MED 1999;131:409-416.
ABSTRACT
| FULL TEXT
Carnitine Stands on Its Own in HIV Infection Treatment
Famularo et al.
Arch Intern Med 1999;159:1143-1144.
FULL TEXT
Complementary and Alternative Medicine Use Among HIV+ Patients
JWatch General 1998;1998:5-5.
FULL TEXT
|
